{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T03:05:05Z","timestamp":1789700705380,"version":"4.0.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100016616","name":"Cystic Fibrosis Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016616","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK126070, EY036139"],"award-info":[{"award-number":["DK126070, EY036139"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002997","name":"Nierstichting","doi-asserted-by":"publisher","award":["21OK+013"],"award-info":[{"award-number":["21OK+013"]}],"id":[{"id":"10.13039\/501100002997","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pflugers Arch - Eur J Physiol"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Pharmacological inhibition of the chloride-bicarbonate exchanger pendrin with PDSinh-C01 potentiates the diuretic action of furosemide in healthy mice. Because pendrin contributes to acid-base regulation and blood pressure control, it may represent an attractive therapeutic target in chronic kidney disease (CKD). We investigated whether this pendrin inhibitor improves metabolic acidosis and salt-sensitive hypertension in the 5\/6 nephrectomy (5\/6Nx) model of CKD. Seven-week-old female Sprague Dawley rats underwent 5\/6Nx and implantation of telemetry devices for blood pressure monitoring. All animals received a high-salt (2% NaCl) diet and were randomized (n = 7\u20139\/group) to daily subcutaneous injections for three days of vehicle, PDSinh-C01 (10 mg\/kg), furosemide (6 mg\/kg), or their combination. The 5\/6Nx model recapitulated key features of CKD, including reduced eGFR, hypertension, proteinuria, and hyperchloremic metabolic acidosis. Combination therapy produced the greatest reduction in mean arterial pressure (-11 \u00b1 2 mmHg) compared with vehicle (-3 \u00b1 2 mmHg), furosemide (-6 \u00b1 1 mmHg), or pendrin inhibitor alone (-6 \u00b1 2 mmHg). Furosemide and combination therapy increased urine volume at 6h, whereas only combination therapy increased urine volume at 24h. After three days, the pendrin inhibitor alone and combination therapy increased venous bicarbonate concentrations compared with vehicle (24.5 \u00b1 2.1 and 24.3 \u00b1 1.4 vs. 21.4 \u00b1 1.4 mmol\/l). In conclusion, PDSinh-C01 combined with furosemide improves salt-sensitive hypertension in CKD, while PDSinh-C01 alone and in combination with furosemide ameliorates metabolic acidosis. These findings support pendrin as a regulator of electrolyte and acid-base balance and as a potential therapeutic target in CKD.<\/jats:p>","DOI":"10.1007\/s00424-026-03205-9","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T04:01:10Z","timestamp":1786939270000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pendrin inhibitor PDSinh-C01 reverses salt-sensitive hypertension and metabolic acidosis in the 5\/6 nephrectomy rat model"],"prefix":"10.1007","volume":"478","author":[{"given":"Crissy F.","family":"Rudolphi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yo\u00eblle","family":"Goos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usha","family":"Musterd-Bhaggoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"van Veghel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid M.","family":"Garrelds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. H. Jan","family":"Danser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy","family":"Karmakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onur","family":"Cil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro H.","family":"Imenez Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8738-3571","authenticated-orcid":false,"given":"Ewout J.","family":"Hoorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"key":"3205_CR1","doi-asserted-by":"publisher","first-page":"4221","DOI":"10.1073\/pnas.071516798","volume":"98","author":"IE Royaux","year":"2001","unstructured":"Royaux IE, Wall SM, Karniski LP, Everett LA, Suzuki K, Knepper MA, Green ED (2001) Pendrin, encoded by the Pendred syndrome gene, resides in the apical region of renal intercalated cells and mediates bicarbonate secretion. Proc Natl Acad Sci U S A 98:4221\u20134226","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3205_CR2","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00424-023-02897-7","volume":"476","author":"F Brazier","year":"2024","unstructured":"Brazier F, Corniere N, Picard N, Chambrey R, Eladari D (2024) Pendrin: linking acid base to blood pressure. Pflugers Arch 476:533\u2013543","journal-title":"Pflugers Arch"},{"key":"3205_CR3","doi-asserted-by":"publisher","first-page":"F193","DOI":"10.1152\/ajprenal.00400.2015","volume":"310","author":"SM Wall","year":"2016","unstructured":"Wall SM (2016) The role of pendrin in blood pressure regulation. Am J Physiol Ren Physiol 310:F193\u2013203","journal-title":"Am J Physiol Ren Physiol"},{"key":"3205_CR4","doi-asserted-by":"publisher","first-page":"13368","DOI":"10.1073\/pnas.1202671109","volume":"109","author":"M Soleimani","year":"2012","unstructured":"Soleimani M, Barone S, Xu J, Shull GE, Siddiqui F, Zahedi K, Amlal H (2012) Double knockout of pendrin and Na-Cl cotransporter (NCC) causes severe salt wasting, volume depletion, and renal failure. Proc Natl Acad Sci U S A 109:13368\u201313373","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3205_CR5","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1093\/ndt\/gfw393","volume":"32","author":"F Trepiccione","year":"2017","unstructured":"Trepiccione F, Soukaseum C, Baudrie V, Kumai Y, Teulon J, Villoutreix B, Corni\u00e8re N, Wangemann P, Griffith AJ, Byung Choi Y, Hadchouel J, Chambrey R, Eladari D (2017) Acute genetic ablation of pendrin lowers blood pressure in mice. Nephrol Dial Transpl 32:1137\u20131145","journal-title":"Nephrol Dial Transpl"},{"key":"3205_CR6","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1161\/01.HYP.0000088321.67254.B7","volume":"42","author":"JW Verlander","year":"2003","unstructured":"Verlander JW, Hassell KA, Royaux IE, Glapion DM, Wang ME, Everett LA, Green ED, Wall SM (2003) Deoxycorticosterone upregulates PDS (Slc26a4) in mouse kidney: role of pendrin in mineralocorticoid-induced hypertension. Hypertension 42:356\u2013362","journal-title":"Hypertension"},{"key":"3205_CR7","doi-asserted-by":"publisher","first-page":"3706","DOI":"10.1681\/ASN.2015121312","volume":"27","author":"O Cil","year":"2016","unstructured":"Cil O, Haggie PM, Phuan PW, Tan JA, Verkman AS (2016) Small-Molecule Inhibitors of Pendrin Potentiate the Diuretic Action of Furosemide. J Am Soc Nephrol 27:3706\u20133714","journal-title":"J Am Soc Nephrol"},{"key":"3205_CR8","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/s41581-024-00918-x","volume":"21","author":"R Agarwal","year":"2025","unstructured":"Agarwal R, Verma A, Georgianos PI (2025) Diuretics in patients with chronic kidney disease. Nat Rev Nephrol 21:264\u2013278","journal-title":"Nat Rev Nephrol"},{"key":"3205_CR9","doi-asserted-by":"publisher","first-page":"F1005","DOI":"10.1152\/ajprenal.00195.2024","volume":"327","author":"KY Wei","year":"2024","unstructured":"Wei KY, Gritter M, Danser AHJ, Vogt L, de Borst MH, Rotmans JI, Imenez Silva PH, Hoorn EJ (2024) 5\/6 Nephrectomy Impairs Acute Kaliuretic Responses and Predisposes to Postprandial Hyperkalemia. Am J Physiol Ren Physiol 327:F1005\u2013F1012","journal-title":"Am J Physiol Ren Physiol"},{"key":"3205_CR10","doi-asserted-by":"publisher","first-page":"F62","DOI":"10.1152\/ajprenal.00668.2016","volume":"313","author":"G Frindt","year":"2017","unstructured":"Frindt G, Yang L, Uchida S, Weinstein AM, Palmer LG (2017) Responses of distal nephron Na(+) transporters to acute volume depletion and hyperkalemia. Am J Physiol Ren Physiol 313:F62\u2013F73","journal-title":"Am J Physiol Ren Physiol"},{"key":"3205_CR11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1161\/01.HYP.24.1.37","volume":"24","author":"AH Danser","year":"1994","unstructured":"Danser AH, van Kats JP, Admiraal PJ, Derkx FH, Lamers JM, Verdouw PD, Saxena PR, Schalekamp MA (1994) Cardiac renin and angiotensins. Uptake from plasma versus in situ synthesis. Hypertension 24:37\u201348","journal-title":"Hypertension"},{"key":"3205_CR12","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1161\/HYPERTENSIONAHA.124.22878","volume":"81","author":"D Ye","year":"2024","unstructured":"Ye D, Cruz-L\u00f3pez EO, Veghel RV, Garrelds IM, Kasper A, Wassarman K, Tu HC, Zlatev I, Danser AHJ (2024) Counteracting Angiotensinogen Small-Interfering RNA-Mediated Antihypertensive Effects With REVERSIR. Hypertension 81:1491\u20131499","journal-title":"Hypertension"},{"key":"3205_CR13","doi-asserted-by":"publisher","first-page":"F518","DOI":"10.1152\/ajprenal.00656.2020","volume":"320","author":"PJ Besseling","year":"2021","unstructured":"Besseling PJ, Pieters TT, Nguyen ITN, de Bree PM, Willekes N, Dijk AH, Bov\u00e9e DM, Hoorn EJ, Rookmaaker MB, Gerritsen KG, Verhaar MC, Gremmels H, Joles JA (2021) A plasma creatinine- and urea-based equation to estimate glomerular filtration rate in rats. Am J Physiol Ren Physiol 320:F518\u2013F524","journal-title":"Am J Physiol Ren Physiol"},{"key":"3205_CR14","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.2215\/CJN.0000000000000195","volume":"18","author":"PM Ferraro","year":"2023","unstructured":"Ferraro PM, Taylor EN, Asplin JR, Curhan GC (2023) Associations between Net Gastrointestinal Alkali Absorption, 24-Hour Urine Lithogenic Factors, and Kidney Stones. Clin J Am Soc Nephrol 18:1068\u20131074","journal-title":"Clin J Am Soc Nephrol"},{"key":"3205_CR15","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1161\/HYPERTENSIONAHA.116.08207","volume":"68","author":"A Dayton","year":"2016","unstructured":"Dayton A, Exner EC, Bukowy JD, Stodola TJ, Kurth T, Skelton M, Greene AS, Cowley AW Jr (2016) Breaking the Cycle: Estrous Variation Does Not Require Increased Sample Size in the Study of Female Rats. Hypertension 68:1139\u20131144","journal-title":"Hypertension"},{"key":"3205_CR16","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1172\/JCI113847","volume":"83","author":"DH Ellison","year":"1989","unstructured":"Ellison DH, Velazquez H, Wright FS (1989) Adaptation of the distal convoluted tubule of the rat. Structural and functional effects of dietary salt intake and chronic diuretic infusion. J Clin Invest 83:113\u2013126","journal-title":"J Clin Invest"},{"key":"3205_CR17","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1097\/MNH.0000000000000725","volume":"30","author":"P Berg","year":"2021","unstructured":"Berg P, Jeppesen M, Leipziger J (2021) Cystic fibrosis in the kidney: new lessons from impaired renal HCO3- excretion. Curr Opin Nephrol Hypertens 30:437\u2013443","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"3205_CR18","first-page":"F731","volume":"263","author":"C Pupilli","year":"1992","unstructured":"Pupilli C, Chevalier RL, Carey RM, Gomez RA (1992) Distribution and content of renin and renin mRNA in remnant kidney of adult rat. Am J Physiol 263:F731\u2013738","journal-title":"Am J Physiol"},{"key":"3205_CR19","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.2215\/CJN.16041219","volume":"15","author":"M Emmett","year":"2020","unstructured":"Emmett M (2020) Metabolic Alkalosis: A Brief Pathophysiologic Review. Clin J Am Soc Nephrol 15:1848\u20131856","journal-title":"Clin J Am Soc Nephrol"},{"key":"3205_CR20","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1172\/JCI114321","volume":"84","author":"DE Wesson","year":"1989","unstructured":"Wesson DE (1989) Augmented bicarbonate reabsorption by both the proximal and distal nephron maintains chloride-deplete metabolic alkalosis in rats. J Clin Invest 84:1460\u20131469","journal-title":"J Clin Invest"},{"key":"3205_CR21","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1152\/physrev.00011.2019","volume":"100","author":"SM Wall","year":"2020","unstructured":"Wall SM, Verlander JW, Romero CA (2020) The Renal Physiology of Pendrin-Positive Intercalated Cells. Physiol Rev 100:1119\u20131147","journal-title":"Physiol Rev"},{"key":"3205_CR22","doi-asserted-by":"publisher","first-page":"F654","DOI":"10.1152\/ajprenal.00603.2020","volume":"320","author":"DM Bovee","year":"2021","unstructured":"Bovee DM, Uijl E, Severs D, Rubio-Beltran E, van Veghel R, van den Maassen A, Joles JA, Zietse R, Cuevas CA, Danser AHJ, Hoorn EJ (2021) Dietary salt modifies the blood pressure response to renin-angiotensin inhibition in experimental chronic kidney disease. Am J Physiol Ren Physiol 320:F654\u2013F668","journal-title":"Am J Physiol Ren Physiol"},{"key":"3205_CR23","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1681\/ASN.2009121257","volume":"21","author":"V Pech","year":"2010","unstructured":"Pech V, Pham TD, Hong S, Weinstein AM, Spencer KB, Duke BJ, Walp E, Kim YH, Sutliff RL, Bao HF, Eaton DC, Wall SM (2010) Pendrin modulates ENaC function by changing luminal HCO3. J Am Soc Nephrol 21:1928\u20131941","journal-title":"J Am Soc Nephrol"},{"key":"3205_CR24","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1681\/ASN.2016070720","volume":"27","author":"CA Wagner","year":"2016","unstructured":"Wagner CA (2016) Pendrin-A New Target for Diuretic Therapy? J Am Soc Nephrol 27:3499\u20133501","journal-title":"J Am Soc Nephrol"},{"key":"3205_CR25","doi-asserted-by":"publisher","first-page":"40926","DOI":"10.1038\/s41598-025-24241-y","volume":"15","author":"JS Choi","year":"2025","unstructured":"Choi JS, Shin MH, Oh GE, Song DN, NamKung W, Han GH, Choi JY, Park MS (2025) Pendrin inhibition is associated with protective effect of prone positioning in a ventilator-induced lung injury mouse model. Sci Rep 15:40926","journal-title":"Sci Rep"},{"key":"3205_CR26","doi-asserted-by":"publisher","first-page":"117133","DOI":"10.1016\/j.ejmech.2024.117133","volume":"283","author":"RJ Master","year":"2024","unstructured":"Master RJ, Karmakar J, Haggie PM, Anthony-Tan J, Chu T, Verkman AS, Anderson MO, Cil O (2024) High potency 3-carboxy-2-methylbenzofuran pendrin inhibitors as novel diuretics. Eur J Med Chem 283:117133","journal-title":"Eur J Med Chem"}],"container-title":["Pfl\u00fcgers Archiv - European Journal of Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00424-026-03205-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00424-026-03205-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00424-026-03205-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T02:27:16Z","timestamp":1789698436000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00424-026-03205-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,17]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["3205"],"URL":"https:\/\/doi.org\/10.1007\/s00424-026-03205-9","relation":{},"ISSN":["0031-6768","1432-2013"],"issn-type":[{"value":"0031-6768","type":"print"},{"value":"1432-2013","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,17]]},"assertion":[{"value":"28 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal procedures were approved by the Animal Welfare Body of the Erasmus Medical Center (license AVD10100202317030).","order":1,"name":"Ethics","label":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No conflicts of interest, financial or otherwise, are declared by the authors.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"75"}}